# Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

> clinical trial · VERIFIED · 2026-08-21

Status: COMPLETED · Sponsor: Eli Lilly and Company · Condition: Cognition Disorders

- Company: Eli Lilly and Company
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT02008357

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.